C61 Billable / specific Malignant neoplasm of prostate

ICD-10-CM C61 identifies “Malignant neoplasm of prostate” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 2: Neoplasms

Code-level instructions

Excludes 11

malignant neoplasm of seminal vesicle (C63.7)

Use additional code3
  • code, if applicable, to identify:
  • hormone sensitivity status (Z19.1-Z19.2)
  • rising PSA following treatment for malignant neoplasm of prostate (R97.21)

Inherited instructions

Chapters 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C60-C63 · Malignant neoplasms of male genital organs (C60-C63)

Includes1

malignant neoplasm of skin of male genital organs

Official index references

Official index references (4)

Adenocarcinoma (1)
Carcinoma(malignant) (1)
Cystadenocarcinoma (1)
Neoplasm, neoplastic (1)
References from other codes (2)
History

Code history

Latest recorded change · FY2023

ChangedUnchanged
FY2023

Effective from

  • Code-level rules changed

Malignant neoplasm of prostate

Billable diagnosis code

CDC/NCHS · FY2023

All editions (19)

All editionsEffective fromCode history
FY20162015-10-01First observed
FY20172016-10-01Code-level rules changed
FY20182017-10-01No tabular change
FY20192018-10-01No tabular change
FY20202019-10-01No tabular change
FY2020 · April2020-04-01No tabular change
FY20212020-10-01No tabular change
FY2021 · 01-012021-01-01No tabular change
FY20222021-10-01No tabular change
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01Code-level rules changed
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change
Historical ICD-9 mappings · 2018

Historical mapping only; not an automatic code substitution.

  • 185

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.